LivaNova LIVN
NASDAQ LIVN
$78.96 -1.74 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

LivaNova (LIVN) EBIT Margin Growth (3y) (2019 - 2026)

Analysis

LivaNova (LIVN) EBIT Margin Growth (3y) (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -201.00
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 722.00
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 162.00
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 586.00
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 736.00
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 887.00
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -1,075.00
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 963.00
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 244.00
10 LivaNova 4.34 Bn 3.82 Bn 273.67 Mn 676.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 676.00
Mar 31, 2026 1,234.00
Dec 31, 2025 672.00
Sep 30, 2025 6,734.00
Jun 30, 2025 288.00
Mar 31, 2025 1,139.00
Dec 31, 2024 234.00
Sep 30, 2024 471.00
Jun 30, 2024 2,632.00
Mar 31, 2024 781.00
Dec 31, 2023 6,401.00
Sep 30, 2023 470.00
Jun 30, 2023 1,510.00
Mar 31, 2023 -65.00
Dec 31, 2022 5,514.00
Sep 30, 2022 -6,184.00
Jun 30, 2022 2,327.00
Mar 31, 2022 1,224.00
Dec 31, 2021 10,225.00
Sep 30, 2021 860.00